Guo J - Search Results

1

Post-treatment tumor gene expression signatures are more predictive of treatment outcomes than baseline signatures in breast cancer.

Lee SC, Xu X, Chng WJ, Watson M, Lim YW, Wong CI, Iau P, Sukri N, Lim SE, Yap HL, Buhari SA, Tan P, Guo J, Chuah B, McLeod HL, Goh BC. Lee SC, et al. Among authors: guo j. Pharmacogenet Genomics. 2009 Nov;19(11):833-42. doi: 10.1097/FPC.0b013e328330a39f. Pharmacogenet Genomics. 2009. PMID: 19809382 Clinical Trial.

2

Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity.

Fan L, Goh BC, Wong CI, Sukri N, Lim SE, Tan SH, Guo JY, Lim R, Yap HL, Khoo YM, Iau P, Lee HS, Lee SC. Fan L, et al. Pharmacogenet Genomics. 2008 Jul;18(7):621-31. doi: 10.1097/FPC.0b013e328301a869. Pharmacogenet Genomics. 2008. PMID: 18551042

3

PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients.

Hor SY, Lee SC, Wong CI, Lim YW, Lim RC, Wang LZ, Fan L, Guo JY, Lee HS, Goh BC, Tan T. Hor SY, et al. Among authors: guo jy. Pharmacogenomics J. 2008 Apr;8(2):139-46. doi: 10.1038/sj.tpj.6500478. Epub 2007 Sep 18. Pharmacogenomics J. 2008. PMID: 17876342 Clinical Trial.

4

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma.

Lee SC, Lim SG, Soo R, Hsieh WS, Guo JY, Putti T, Tao Q, Soong R, Goh BC. Lee SC, et al. Pharmacogenet Genomics. 2006 Jan;16(1):73-4. doi: 10.1097/01.fpc.0000184959.82903.02. Pharmacogenet Genomics. 2006. PMID: 16344724

5

Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinoma.

Wong CI, Yap HL, Lim SG, Guo JY, Goh BC, Lee SC. Wong CI, et al. Hepatol Res. 2008 Aug;38(8):838-41. doi: 10.1111/j.1872-034X.2008.00365.x. Epub 2008 May 7. Hepatol Res. 2008. PMID: 18462377

6

Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies.

Goh BC, Lee SC, Wang LZ, Fan L, Guo JY, Lamba J, Schuetz E, Lim R, Lim HL, Ong AB, Lee HS. Goh BC, et al. Among authors: guo jy. J Clin Oncol. 2002 Sep 1;20(17):3683-90. doi: 10.1200/JCO.2002.01.025. J Clin Oncol. 2002. PMID: 12202670

7

Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population.

Lee SC, Ng SS, Oldenburg J, Chong PY, Rost S, Guo JY, Yap HL, Rankin SC, Khor HB, Yeo TC, Ng KS, Soong R, Goh BC. Lee SC, et al. Among authors: guo jy. Clin Pharmacol Ther. 2006 Mar;79(3):197-205. doi: 10.1016/j.clpt.2005.11.006. Clin Pharmacol Ther. 2006. PMID: 16513444

8

Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore.

Yap HL, Chieng WS, Lim JR, Lim RS, Soo R, Guo J, Lee SC. Yap HL, et al. Among authors: guo j. Fam Cancer. 2009;8(2):85-94. doi: 10.1007/s10689-008-9209-5. Epub 2008 Aug 23. Fam Cancer. 2009. PMID: 18726168

9

A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.

Tham LS, Goh BC, Nafziger A, Guo JY, Wang LZ, Soong R, Lee SC. Tham LS, et al. Clin Pharmacol Ther. 2006 Oct;80(4):346-55. doi: 10.1016/j.clpt.2006.06.009. Clin Pharmacol Ther. 2006. PMID: 17015052

10

Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma.

Chuah BY, Yeo WL, Guo JY, Lim SG, Yap HL, Goh BC, Lee SC. Chuah BY, et al. Acta Oncol. 2009;48(4):628-30. doi: 10.1080/02841860802637781. Acta Oncol. 2009. PMID: 19160077 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,020 results

Search Page

Filters